The Medicines and Healthcare products Regulatory Agency (MHRA) has launched Drug Safety Update, a new monthly electronic bulletin containing the latest information and clinical advice from the MHRA. It is aimed at healthcare professionals and has been designed to allow rapid access to information relevant to an individual's area of clinical practice.
The first bulletin contains several drug safety advice articles (specified below) and information from the Yellow Card scheme, hot topics (including isotretinoin for severe acne and smoking cessation aids) and a reminder of the topics covered in recent letters to healthcare professionals and drug alerts.
- Gadolinium-containing contrast agents and nephrogenic systemic fibrosis
- Extraneal and products that contain (or are metabolised to) maltose, xylose, or galactose: false glucose reading
- Alpha-1-adrenoreceptor antagonists and intraoperative floppy iris syndrome
- Cabergoline: risk of cardiovalvulopathy
- Linezolid: restriction of indication
- Dopamine agonists and pathological gambling, increased libido, and hypersexuality
- Antidepressants and risk of suicidal behaviour
Action: This new monthly summary contains a wealth of drug safety information that all frontline clinicians will find useful. The option to receive a free e-mail notification when a new bulletin is published will provide a timely reminder for busy professionals.
Thanks to Rob Davies for spotting this launch.
|« FDA panel recommends keeping rosiglitazone||NICE accept varenicline »|